International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases

BACKGROUND: Fecal calprotectin (FC) is a non‐invasive marker of gut inflammation which is frequently used to guide therapeutic decisions in patients with inflammatory bowel diseases (IBD). Each step of FC measurement can influence the results, leading to misinterpretations and potentially impacting...

Descripción completa

Detalles Bibliográficos
Autores principales: D'Amico, Ferdinando, Rubin, David T., Kotze, Paulo Gustavo, Magro, Fernando, Siegmund, Britta, Kobayashi, Taku, Olivera, Pablo A., Bossuyt, Peter, Pouillon, Lieven, Louis, Edouard, Domènech, Eugeni, Ghosh, Subrata, Danese, Silvio, Peyrin‐Biroulet, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259254/
https://www.ncbi.nlm.nih.gov/pubmed/33961734
http://dx.doi.org/10.1002/ueg2.12069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259254/
https://www.ncbi.nlm.nih.gov/pubmed/33961734
http://dx.doi.org/10.1002/ueg2.12069

Ejemplares similares